Cargando…
The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities
BACKGROUND: The prevalence rates of freezing of gait (FOG) in Parkinson’s disease (PD) vary widely, ranging from 14.0 to 55.1%. Our aim is to calculate the overall prevalence of FOG in all PD patients with different disease durations and severities. METHODS: Using Medline/PubMed/Embase, we carried o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398304/ https://www.ncbi.nlm.nih.gov/pubmed/32922946 http://dx.doi.org/10.1186/s41016-020-00197-y |
_version_ | 1783565937129029632 |
---|---|
author | Ge, Hong-Liang Chen, Xiao-Yong Lin, Yuan-Xiang Ge, Ting-Juan Yu, Liang-Hong Lin, Zhang-Ya Wu, Xi-Yue Kang, De-Zhi Ding, Chen-Yu |
author_facet | Ge, Hong-Liang Chen, Xiao-Yong Lin, Yuan-Xiang Ge, Ting-Juan Yu, Liang-Hong Lin, Zhang-Ya Wu, Xi-Yue Kang, De-Zhi Ding, Chen-Yu |
author_sort | Ge, Hong-Liang |
collection | PubMed |
description | BACKGROUND: The prevalence rates of freezing of gait (FOG) in Parkinson’s disease (PD) vary widely, ranging from 14.0 to 55.1%. Our aim is to calculate the overall prevalence of FOG in all PD patients with different disease durations and severities. METHODS: Using Medline/PubMed/Embase, we carried out a systematic literature search for studies reporting the PD and clinically relevant FOG. RESULTS: After primary screening, a total of 35 studies were identified and further analyzed for inclusion into the analysis, and 29 studies fulfilled the quality criteria and included in this meta-analysis. The overall prevalence of FOG in PD was 39.9% (95% CI 35.3-44.5%). The FOG identified by the freezing of gait questionnaire item 3 may be more prevalent (43.8%, 95% CI 38.5-49.1%) than the FOG identified by the Unified Parkinson’s Disease Rating Scale item 14 (36.0%, 95% CI 29.0-43.1%). Disease duration and severity are both the clinical features associated with the FOG. The highest FOG prevalence rate in PD patients was seen in patients with disease durations ≥ 10 years, at 70.8%, followed that of PD patients with disease durations ≥ 5 years (53.3%), and PD patients with disease durations < 5 years (22.4%). FOG presented in 28.4% of PD patients with Hoehn and Yahr staging (H&Y) score ≤ 2.5, and in 68.4% of PD patients with H&Y score ≥ 2.5. CONCLUSION: This meta-analysis confirms that the prevalence of FOG in PD is considerable, and highlights the need for accurate identification of FOG in PD. |
format | Online Article Text |
id | pubmed-7398304 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73983042020-09-10 The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities Ge, Hong-Liang Chen, Xiao-Yong Lin, Yuan-Xiang Ge, Ting-Juan Yu, Liang-Hong Lin, Zhang-Ya Wu, Xi-Yue Kang, De-Zhi Ding, Chen-Yu Chin Neurosurg J Research BACKGROUND: The prevalence rates of freezing of gait (FOG) in Parkinson’s disease (PD) vary widely, ranging from 14.0 to 55.1%. Our aim is to calculate the overall prevalence of FOG in all PD patients with different disease durations and severities. METHODS: Using Medline/PubMed/Embase, we carried out a systematic literature search for studies reporting the PD and clinically relevant FOG. RESULTS: After primary screening, a total of 35 studies were identified and further analyzed for inclusion into the analysis, and 29 studies fulfilled the quality criteria and included in this meta-analysis. The overall prevalence of FOG in PD was 39.9% (95% CI 35.3-44.5%). The FOG identified by the freezing of gait questionnaire item 3 may be more prevalent (43.8%, 95% CI 38.5-49.1%) than the FOG identified by the Unified Parkinson’s Disease Rating Scale item 14 (36.0%, 95% CI 29.0-43.1%). Disease duration and severity are both the clinical features associated with the FOG. The highest FOG prevalence rate in PD patients was seen in patients with disease durations ≥ 10 years, at 70.8%, followed that of PD patients with disease durations ≥ 5 years (53.3%), and PD patients with disease durations < 5 years (22.4%). FOG presented in 28.4% of PD patients with Hoehn and Yahr staging (H&Y) score ≤ 2.5, and in 68.4% of PD patients with H&Y score ≥ 2.5. CONCLUSION: This meta-analysis confirms that the prevalence of FOG in PD is considerable, and highlights the need for accurate identification of FOG in PD. BioMed Central 2020-05-14 /pmc/articles/PMC7398304/ /pubmed/32922946 http://dx.doi.org/10.1186/s41016-020-00197-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ge, Hong-Liang Chen, Xiao-Yong Lin, Yuan-Xiang Ge, Ting-Juan Yu, Liang-Hong Lin, Zhang-Ya Wu, Xi-Yue Kang, De-Zhi Ding, Chen-Yu The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities |
title | The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities |
title_full | The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities |
title_fullStr | The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities |
title_full_unstemmed | The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities |
title_short | The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities |
title_sort | prevalence of freezing of gait in parkinson’s disease and in patients with different disease durations and severities |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398304/ https://www.ncbi.nlm.nih.gov/pubmed/32922946 http://dx.doi.org/10.1186/s41016-020-00197-y |
work_keys_str_mv | AT gehongliang theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT chenxiaoyong theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT linyuanxiang theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT getingjuan theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT yulianghong theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT linzhangya theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT wuxiyue theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT kangdezhi theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT dingchenyu theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT gehongliang prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT chenxiaoyong prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT linyuanxiang prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT getingjuan prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT yulianghong prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT linzhangya prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT wuxiyue prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT kangdezhi prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities AT dingchenyu prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities |